What Does Triple Agonist Mean for Retatrutide?
Short answer: An agonist is a molecule that activates a receptor. Retatrutide is a single peptide engineered to activate three: the GLP-1 receptor, the GIP receptor and the glucagon receptor. Semaglutide acts on one of these and tirzepatide on two, so Retatrutide is the first compound in late-stage trials to combine all three in one molecule.
The three receptors sit in different tissues and signal different things — the incretin receptors in the pancreas and brain, the glucagon receptor mainly in the liver — and the Coskun 2022 paper describes balancing the activity at each so that one molecule produces a combined effect.
The term describes pharmacology, not an outcome. What the combination did in people is the subject of the trial papers, cited on their own pages.
REVIVE LAB UAE supplies the pack for laboratory research use only. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.
Retatrutide Pack 20 mg — REVIVE LAB UAE
AED 1010 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order Retatrutide Pack UAE — Live Stock & Pricing
AED 1010 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order Retatrutide Pack UAE — Live Stock & Pricing
Research-Use Only Disclaimer: This page is published for laboratory and scientific research information purposes only. Nothing here constitutes medical advice, dosing guidance, or a therapeutic recommendation. Products supplied by REVIVE LAB UAE (revivelab.ae) — where applicable — are sold strictly as reference materials for research use, not for human or veterinary consumption. Buyers and readers are solely responsible for compliance with applicable UAE laws and institutional research ethics requirements.